Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...
Tonix Pharmaceuticals (NASDAQ: TNXP) will implement a 1-for-100 reverse stock split, effective at <a target=_blank href= ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback